March 31, 2026 Rare/Orphan and Pediatric Disease Programs: Quarterly Newsletter March 2026 Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
February 12, 2026 Building the Infrastructure of Hope Medical history is usually written as a chronicle of individual breakthroughs. We learn about Fleming discovering penicillin...
December 12, 2025 Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease Autosomal dominant polycystic kidney disease (ADPKD) is the most...
June 26, 2025 The Critical Path Institute Podcast: Connecting the Dots with DCC This newest Critical Path Institute® (C-Path) podcast episode provides an in-depth exploration of one of C-Path's core teams...
January 9, 2018 Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
January 6, 2018 Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
April 26, 2018 CPTR Newsletter – April 2018 CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora
March 24, 2018 Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis WHO adopts ReSeqTB as bioinformatics platform for TB surveillance, enabling the global scale-up of culture-free,
